Testing effectiveness (Phase 2)Ended earlyNCT05839509What this trial is testingPhase 2 Clinical Trial of GH001 in Bipolar II DisorderWho this might be right forBipolar II Disorder GH Research Ireland Limited 6
Testing effectiveness (Phase 2)UnknownNCT03396744What this trial is testingBright Light Therapy in the Treatment of Non-seasonal Bipolar DepressionWho this might be right forBipolar Depression Assistance Publique - Hôpitaux de Paris 45
Testing effectiveness (Phase 2)Study completedNCT04133233What this trial is testingLow Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar DisorderWho this might be right forBipolar Depression Assistance Publique - Hôpitaux de Paris 14
Not applicableLooking for participantsNCT05828056What this trial is testingPrediction on the Recurrence of Manic and Depressive Episodes in Bipolar DisorderWho this might be right forBipolar DisorderDepressive Disorder National Taiwan University Hospital 100
Large-scale testing (Phase 3)Study completedNCT01725308What this trial is testingEvaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesWho this might be right forBipolar Disorder Astellas Pharma Inc 431
Large-scale testing (Phase 3)Study completedNCT00094432What this trial is testingAripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeWho this might be right forBipolar I Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 650
Testing effectiveness (Phase 2)Study completedNCT06605599What this trial is testingStudy of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II DisorderWho this might be right forBipolar I DisorderBipolar II Disorder AbbVie 161
Large-scale testing (Phase 3)Study completedNCT02600494What this trial is testingClinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar DepressionWho this might be right forBipolar Depression Intra-Cellular Therapies, Inc. 554